Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
Doyle, A E
Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients? [electronic resource] - Journal of hypertension. Supplement : official journal of the International Society of Hypertension Dec 1988 - S51-3 p. digital
Publication Type: Journal Article; Review
0952-1178
Adrenergic alpha-Antagonists--therapeutic use
Antihypertensive Agents--therapeutic use
Humans
Hypertension--drug therapy
Ketanserin--therapeutic use
Labetalol--therapeutic use
Piperazines--therapeutic use
Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients? [electronic resource] - Journal of hypertension. Supplement : official journal of the International Society of Hypertension Dec 1988 - S51-3 p. digital
Publication Type: Journal Article; Review
0952-1178
Adrenergic alpha-Antagonists--therapeutic use
Antihypertensive Agents--therapeutic use
Humans
Hypertension--drug therapy
Ketanserin--therapeutic use
Labetalol--therapeutic use
Piperazines--therapeutic use